Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Saniona

15.83 SEK

+1.87 %

Less than 1K followers

SANION

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Saniona

2019202020212022202320242025
Revenue2.78.210.515.316.8334.7434.4
growth-%208.4 %27.8 %45.8 %10.2 %1,887.4 %29.8 %
EBITDA-101.7-156.0-402.9-217.9-71.4249.6277.8
EBIT-103.9-159.4-411.6-225.7-81.1241.9271.0
Profit before taxes-83.5-81.2-418.4-252.0-104.3207.0306.0
Net income-75.8-73.4-410.9-245.4-95.8188.7284.7
EPS-2.50-1.52-5.57-3.33-1.261.772.21
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %0.0 %0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-3,826.3 %-1,902.5 %-3,845.2 %-1,426.0 %-424.1 %74.6 %63.9 %
EBIT-%-3,909.2 %-1,944.1 %-3,927.9 %-1,477.2 %-481.4 %72.3 %62.4 %
ROE-129.7 %-12.2 %-145.7 %-465.5 %436.7 %81.4 %44.8 %
ROI-78.9 %-10.5 %-93.3 %-159.6 %-151.7 %55.5 %41.9 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.